20 Facts About Kenneth Ouriel

Kenneth Ouriel was born on October 21,1956 and is a vascular surgeon and medical researcher.

In 2007, Ouriel was appointed the chief executive officer of Sheikh Khalifa Medical City in Abu Dhabi.

Kenneth Ouriel has been described as one of America's top vascular surgeons.

Kenneth Ouriel was born in Rochester, New York, entered college at age 16, majored in biology and psychology at the University of Rochester and belonged to the fraternity Alpha Delta Phi.

Kenneth Ouriel studied medicine at the University of Chicago and graduated in 1981 with Honors.

Kenneth Ouriel began a residency in general surgery at the University of Rochester Medical Center and completed a vascular surgical fellowship in 1987.

Kenneth Ouriel got a National Institutes of Health grant to study thrombosis and published results from a large, multicenter randomized trial of clot busting therapy in The New England Journal of Medicine in 1998.

Kenneth Ouriel was promoted to Chief of Surgery in 2003 where he supervised 340 surgeons in the largest surgical department in the world.

Kenneth Ouriel authored three textbooks in vascular surgery and over 250 original scientific articles on a wide variety of vascular surgical topics, focusing on minimally invasive means to treat vascular disease.

In 2001, he treated former presidential candidate Bob Dole who, at age 77, had an abdominal aortic aneurysm; Kenneth Ouriel led a team of surgeons that inserted a stent graft.

Kenneth Ouriel was the principal investigator on a five-year $5 million National Institutes of Health grant to study intravascular ultrasound regarding atherosclerotic plaque.

In June 2007, Kenneth Ouriel became chief executive officer of Sheikh Khalifa Medical City in Abu Dhabi, when Cleveland Clinic and the Abu Dhabi health authority formed a partnership in which the Clinic took over management of the health care facilities.

In that connection, Kenneth Ouriel matriculated in an Executive MBA program in global business jointly run by Columbia Business School and the London Business School.

Kenneth Ouriel worked on upgrade systems involving the future hospital's financial, decision-support management, inventory control and medical productivity software.

Kenneth Ouriel was the CEO of the Sheikh Khalifa Medical City.

Kenneth Ouriel completed his master's degree in business administration from Columbia and London Business Schools.

Kenneth Ouriel facilitated the development of the first permanent renal transplantation program in the United Arab Emirates, where the Sheikh Khalifa team performed their first kidney transplant in early 2008.

In June 2008, Kenneth Ouriel became senior vice president and chief of international operations at New York-Presbyterian.

In 2009, Kenneth Ouriel made speeches to medical professionals about such topics as retaining patients and public-private partnerships.

In 2010, Kenneth Ouriel founded Syntactx, a contract medical research company that provides support for diagnostic labs, medical device and pharmaceutical companies in designing and carrying out clinical research trials, and thereafter led the company.